BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 33112766)

  • 1. The SLC7A11: sperm mitochondrial function and non-canonical glutamate metabolism.
    Ortiz-Rodríguez JM; Martín-Cano FE; Gaitskell-Phillips G; Silva A; Tapia JA; Gil MC; Redondo E; Masot J; Ortega-Ferrusola C; Peña FJ
    Reproduction; 2020 Dec; 160(6):803-818. PubMed ID: 33112766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The incorporation of cystine by the soluble carrier family 7 member 11 (SLC7A11) is a component of the redox regulatory mechanism in stallion spermatozoa†.
    Ortiz-Rodriguez JM; Martín-Cano FE; Ortega-Ferrusola C; Masot J; Redondo E; Gázquez A; Gil MC; Aparicio IM; Rojo-Domínguez P; Tapia JA; Rodriguez-Martínez H; Peña FJ
    Biol Reprod; 2019 Jul; 101(1):208-222. PubMed ID: 30998234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The inhibition of spermatic cystine/glutamate antiporter xCT (SLC7A11) influences the ability of cryopreserved stallion sperm to bind to heterologous zonae pellucidae.
    Ortiz-Rodriguez JM; Nerozzi C; Bucci D; Mislei B; Mari G; Tamanini C; Peña FJ; Spinaci M; Galeati G
    Theriogenology; 2021 Jun; 167():24-31. PubMed ID: 33743505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutaminolysis-related genes determine sensitivity to xCT-targeted therapy in head and neck squamous cell carcinoma.
    Okazaki S; Umene K; Yamasaki J; Suina K; Otsuki Y; Yoshikawa M; Minami Y; Masuko T; Kawaguchi S; Nakayama H; Banno K; Aoki D; Saya H; Nagano O
    Cancer Sci; 2019 Nov; 110(11):3453-3463. PubMed ID: 31444923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cystine-glutamate antiporter xCT as a therapeutic target for cancer.
    Liu L; Liu R; Liu Y; Li G; Chen Q; Liu X; Ma S
    Cell Biochem Funct; 2021 Mar; 39(2):174-179. PubMed ID: 32749001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depletion of thiols leads to redox deregulation, production of 4-hydroxinonenal and sperm senescence: a possible role for GSH regulation in spermatozoa†.
    Ortega-Ferrusola C; Martin Muñoz P; Ortiz-Rodriguez JM; Anel-López L; Balao da Silva C; Álvarez M; de Paz P; Tapia JA; Anel L; Silva-Rodríguez A; Aitken RJ; Gil MC; Gibb Z; Peña FJ
    Biol Reprod; 2019 Apr; 100(4):1090-1107. PubMed ID: 30418487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of ferroptotic cell death for overcoming cisplatin resistance of head and neck cancer.
    Roh JL; Kim EH; Jang HJ; Park JY; Shin D
    Cancer Lett; 2016 Oct; 381(1):96-103. PubMed ID: 27477897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-dependent oxidation of extracellular cysteine/cystine redox state (E
    Zheng Y; Ritzenthaler JD; Burke TJ; Otero J; Roman J; Watson WH
    Free Radic Biol Med; 2018 Apr; 118():13-22. PubMed ID: 29458149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy.
    Koppula P; Zhuang L; Gan B
    Protein Cell; 2021 Aug; 12(8):599-620. PubMed ID: 33000412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stress-induced inhibition of nonsense-mediated RNA decay regulates intracellular cystine transport and intracellular glutathione through regulation of the cystine/glutamate exchanger SLC7A11.
    Martin L; Gardner LB
    Oncogene; 2015 Aug; 34(32):4211-8. PubMed ID: 25399695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenomic approach reveals a role for the x(c)- cystine/glutamate antiporter in growth and celastrol resistance of glioma cell lines.
    Pham AN; Blower PE; Alvarado O; Ravula R; Gout PW; Huang Y
    J Pharmacol Exp Ther; 2010 Mar; 332(3):949-58. PubMed ID: 20007406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cystine/Glutamate antiporter system xc- deficiency impairs macrophage glutathione metabolism and cytokine production.
    de Baat A; Meier DT; Fontana A; Böni-Schnetzler M; Donath MY
    PLoS One; 2023; 18(10):e0291950. PubMed ID: 37792774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cystine/cysteine cycle: a redox cycle regulating susceptibility versus resistance to cell death.
    Banjac A; Perisic T; Sato H; Seiler A; Bannai S; Weiss N; Kölle P; Tschoep K; Issels RD; Daniel PT; Conrad M; Bornkamm GW
    Oncogene; 2008 Mar; 27(11):1618-28. PubMed ID: 17828297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cystine transporter regulation of pentose phosphate pathway dependency and disulfide stress exposes a targetable metabolic vulnerability in cancer.
    Liu X; Olszewski K; Zhang Y; Lim EW; Shi J; Zhang X; Zhang J; Lee H; Koppula P; Lei G; Zhuang L; You MJ; Fang B; Li W; Metallo CM; Poyurovsky MV; Gan B
    Nat Cell Biol; 2020 Apr; 22(4):476-486. PubMed ID: 32231310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The glutamate/cystine antiporter SLC7A11/xCT enhances cancer cell dependency on glucose by exporting glutamate.
    Koppula P; Zhang Y; Shi J; Li W; Gan B
    J Biol Chem; 2017 Aug; 292(34):14240-14249. PubMed ID: 28630042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A synthetic lethal drug combination mimics glucose deprivation-induced cancer cell death in the presence of glucose.
    Joly JH; Delfarah A; Phung PS; Parrish S; Graham NA
    J Biol Chem; 2020 Jan; 295(5):1350-1365. PubMed ID: 31914417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of the SLC7A11/glutathione axis causes synthetic lethality in KRAS-mutant lung adenocarcinoma.
    Hu K; Li K; Lv J; Feng J; Chen J; Wu H; Cheng F; Jiang W; Wang J; Pei H; Chiao PJ; Cai Z; Chen Y; Liu M; Pang X
    J Clin Invest; 2020 Apr; 130(4):1752-1766. PubMed ID: 31874110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-Throughput Assay Development for Cystine-Glutamate Antiporter (xc-) Highlights Faster Cystine Uptake than Glutamate Release in Glioma Cells.
    Thomas AG; Sattler R; Tendyke K; Loiacono KA; Hansen H; Sahni V; Hashizume Y; Rojas C; Slusher BS
    PLoS One; 2015; 10(8):e0127785. PubMed ID: 26252954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification, Expression, and Roles of the Cystine/Glutamate Antiporter in Ocular Tissues.
    Martis RM; Knight LJ; Donaldson PJ; Lim JC
    Oxid Med Cell Longev; 2020; 2020():4594606. PubMed ID: 32655769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of System xc(-) by Pharmacological Manipulation of Cellular Thiols.
    Albano R; Raddatz NJ; Hjelmhaug J; Baker DA; Lobner D
    Oxid Med Cell Longev; 2015; 2015():269371. PubMed ID: 25949770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.